Teva charged in US price-fixing investigation | Financial Times
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva shares surge after announcing global opioid settlement
Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports | Ctech
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
